PVCT Key Statistics, Chart & Performance
The current stock price of PVCT is 0.05 null. In the past month the price decreased by -50%. In the past year, price decreased by -90.91%.
About PVCT
Company Profile
Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. The company's product portfolio consists of PV-10 Melanoma, PH-10 Psoriasis, PH-10 Atopic Dermatitis, PV-10 Breast Cancer, PV-10 Liver Metastasis and PV-10 Mechanism of Action which are in clinical trials. Provectus Biopharmaceuticals Inc., formerly known as Provectus Pharmaceuticals, Inc., is based in Knoxville, Tennessee.
Company Info
PROVECTUS BIOPHARMACEUTICALS I
7327 OAK RIDGE HIGHWAY SUITE A
KNOXVILLE TN 37931
CEO: Alfred E. Smith IV
Phone: 866-594-5999
PROVECTUS BIOPHARMACEUTICALS I / PVCT FAQ
What does PVCT do?
Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. The company's product portfolio consists of PV-10 Melanoma, PH-10 Psoriasis, PH-10 Atopic Dermatitis, PV-10 Breast Cancer, PV-10 Liver Metastasis and PV-10 Mechanism of Action which are in clinical trials. Provectus Biopharmaceuticals Inc., formerly known as Provectus Pharmaceuticals, Inc., is based in Knoxville, Tennessee.
Can you provide the latest stock price for PROVECTUS BIOPHARMACEUTICALS I?
The current stock price of PVCT is 0.05 null. The price decreased by -28.57% in the last trading session.
What is the dividend status of PROVECTUS BIOPHARMACEUTICALS I?
PVCT does not pay a dividend.
What is the ChartMill technical and fundamental rating of PVCT stock?
PVCT has a ChartMill Technical rating of 0 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.
Where is PROVECTUS BIOPHARMACEUTICALS I (PVCT) stock traded?
PVCT stock is listed on the NYSE Arca exchange.
What is PROVECTUS BIOPHARMACEUTICALS I worth?
PROVECTUS BIOPHARMACEUTICALS I (PVCT) has a market capitalization of 18.52M null. This makes PVCT a Nano Cap stock.
What is the ownership structure of PROVECTUS BIOPHARMACEUTICALS I (PVCT)?
You can find the ownership structure of PROVECTUS BIOPHARMACEUTICALS I (PVCT) on the Ownership tab.
PVCT Technical Analysis
PVCT Financial Highlights
Over the last trailing twelve months PVCT reported a non-GAAP Earnings per Share(EPS) of -0.05.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 100.15% | ||
| ROA | -257.04% | ||
| ROE | -478.66% | ||
| Debt/Equity | 0 |